Literature DB >> 8866638

Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.

R Nau1, H W Prange.   

Abstract

OBJECTIVE: Assuming linear kinetics, the mean CSF concentrations of an antibacterial in steady state (CssCSF) can be estimated, when the area under the concentration-time curve in CSF after the first dose is known. For this purpose we propose the function CssCSF = AUCCSF.Anticipated dose/Dosing Interval. Applied dose.
RESULTS: Together with the MIC and MBC of the causative pathogen, the estimate is of value in the choice of antibacterial drug and the dosing regimen in central nervous system infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866638     DOI: 10.1007/bf00203787

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Factors influencing the concentration gradient of protein in cerebrospinal fluid.

Authors:  R A FISHMAN; J RANSOHOFF; E F OSSERMAN
Journal:  J Clin Invest       Date:  1958-10       Impact factor: 14.808

2.  Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.

Authors:  R Nau; H W Prange; S Menck; H Kolenda; K Visser; J K Seydel
Journal:  J Antimicrob Chemother       Date:  1992-06       Impact factor: 5.790

Review 3.  Use of antibacterial agents in infections of the central nervous system.

Authors:  D Thea; M Barza
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

4.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.

Authors:  M G Täuber; C A Doroshow; C J Hackbarth; M G Rusnak; T A Drake; M A Sande
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

6.  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.

Authors:  M H Lebel; B J Freij; G A Syrogiannopoulos; D F Chrane; M J Hoyt; S M Stewart; B D Kennard; K D Olsen; G H McCracken
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

7.  Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; P Muth; G Mahr; S Menck; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

8.  Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis.

Authors:  W M Scheld; J P Brodeur
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

Authors:  R Nau; M Kinzig; T Dreyhaupt; H Kolenda; F Sörgel; H W Prange
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; J Martell; S Sharifi; H Kolenda; J Bircher
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

View more
  6 in total

1.  Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.

Authors:  R Nau; M Kinzig-Schippers; F Sörgel; S Schinschke; R Rössing; C Müller; H Kolenda; H W Prange
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 2.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.

Authors:  R Nau; C Lassek; M Kinzig-Schippers; A Thiel; H W Prange; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 5.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

6.  Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  I Lutsar; I R Friedland; L Wubbel; C C McCoig; H S Jafri; W Ng; F Ghaffar; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.